MedTrace Logo

Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting

NCT02037594 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 438

Last updated 2018-10-11

No results posted yet for this study

Summary

This study identifies social and behavioral factors likely to influence PrEP acceptability and adherence among men who have sex with men (MSM), and collaborates with a community health center to evaluate a two-stage intervention to improve PrEP decision-making, as well as persistence and adherence for those who chose to take PrEP.

Conditions

  • Human Immunodeficiency Virus (HIV)

Interventions

BEHAVIORAL

Sexual Health Counseling

This brief intervention presents PrEP within the context of a patient's comprehensive sexual health plan and is designed to enhance decision-making around PrEP use and decrease sexual risk taking.

BEHAVIORAL

Enhanced Adherence Intervention

This brief intervention is provides standard of care PrEP adherence information plus specific counseling, troubleshooting, and support.

BEHAVIORAL

PrEP Information (Active Control)

Standard of Care Information about PrEP

BEHAVIORAL

Standard of Care Adherence Support (Active Control)

Standard of care information and instruction about PrEP adherence.

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Gilead Sciences

    collaborator INDUSTRY

  • Hunter College of City University of New York

    lead OTHER

Principal Investigators

  • Sarit A Golub, PhD, MPH · Hunter College, CUNY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-30
Primary Completion
2017-06-01
Completion
2018-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02037594 on ClinicalTrials.gov